![Max Lataillade](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Lataillade
Hoofd Techniek/Wetenschap/O&O bij
CYTODYN INC.
Profiel
Max Lataillade currently works at Yale University School of Medicine, as Assistant Professor and CytoDyn, Inc., as Senior Vice President & Head-Clinical Development from 2024.
Dr. Lataillade received his doctorate degree from the University of Medicine & Dentistry of New Jersey.
Actieve functies van Max Lataillade
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTODYN INC. | Hoofd Techniek/Wetenschap/O&O | 08-10-2024 |
Opleiding van Max Lataillade
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
